{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:09:00Z","timestamp":1740107340481,"version":"3.37.3"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2020,5,6]],"date-time":"2020-05-06T00:00:00Z","timestamp":1588723200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,5,6]],"date-time":"2020-05-06T00:00:00Z","timestamp":1588723200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1007\/s00417-020-04711-x","type":"journal-article","created":{"date-parts":[[2020,5,6]],"date-time":"2020-05-06T22:02:30Z","timestamp":1588802550000},"page":"1975-1981","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Diagnosis and management of three optic neuropathies: a national survey"],"prefix":"10.1007","volume":"258","author":[{"given":"Haeng-Jin","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyuna","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7540-7129","authenticated-orcid":false,"given":"Ju-Yeun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,5,6]]},"reference":[{"key":"4711_CR1","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1016\/S0002-9394(14)76784-4","volume":"111","author":"NJ Newman","year":"1991","unstructured":"Newman NJ, Lott MT, Wallace DC (1991) The clinical characteristics of pedigrees of Leber's hereditary optic neuropathy with the 11778 mutation. Am J Ophthalmol 111:750\u2013762","journal-title":"Am J Ophthalmol"},{"key":"4711_CR2","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/S0161-6420(96)30665-9","volume":"103","author":"EK Nikoskelainen","year":"1996","unstructured":"Nikoskelainen EK, Huoponen K, Juvonen V, Lamminen T, Nummelin K, Savontaus ML (1996) Ophthalmologic findings in Leber hereditary optic neuropathy, with special reference to mtDNA mutations. Ophthalmology 103:504\u2013514","journal-title":"Ophthalmology"},{"key":"4711_CR3","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1016\/j.ajo.2005.12.045","volume":"141","author":"NJ Newman","year":"2006","unstructured":"Newman NJ, Biousse V, Newman SA, Bhatti MT, Hamilton SR, Farris BK, Lesser RL, Turbin RE (2006) Progression of visual field defects in leber hereditary optic neuropathy: experience of the LHON treatment trial. Am J Ophthalmol 141:1061\u20131067","journal-title":"Am J Ophthalmol"},{"key":"4711_CR4","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1097\/WNO.0000000000000570","volume":"37","author":"V Carelli","year":"2017","unstructured":"Carelli V, Carbonelli M, de Coo IF, Kawasaki A, Klopstock T, Lagreze WA, La Morgia C, Newman NJ, Orssaud C, Pott JWR, Sadun AA, van Everdingen J, Vignal-Clermont C, Votruba M, Yu-Wai-Man P, Barboni P (2017) International consensus statement on the clinical and therapeutic management of Leber hereditary optic neuropathy. J Neuroophthalmol 37:371\u2013381","journal-title":"J Neuroophthalmol"},{"key":"4711_CR5","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1097\/WNO.0b013e31814a5a9a","volume":"27","author":"B Kaderli","year":"2007","unstructured":"Kaderli B, Avci R, Yucel A, Guler K, Gelisken O (2007) Intravitreal triamcinolone improves recovery of visual acuity in nonarteritic anterior ischemic optic neuropathy. J Neuroophthalmol 27:164\u2013168","journal-title":"J Neuroophthalmol"},{"key":"4711_CR6","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1007\/s00417-008-0805-8","volume":"246","author":"SS Hayreh","year":"2008","unstructured":"Hayreh SS, Zimmerman MB (2008) Non-arteritic anterior ischemic optic neuropathy: role of systemic corticosteroid therapy. Graefes Arch Clin Exp Ophthalmol 246:1029\u20131046","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"4711_CR7","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1111\/j.1444-0938.2008.00287.x","volume":"91","author":"A Yaman","year":"2008","unstructured":"Yaman A, Selver OB, Saatci AO, Soylev MF (2008) Intravitreal triamcinolone acetonide injection for acute non-arteritic anterior ischaemic optic neuropathy. Clin Exp Optom 91:561\u2013564","journal-title":"Clin Exp Optom"},{"key":"4711_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/WNO.0000000000000482","volume":"37","author":"MJ Kupersmith","year":"2017","unstructured":"Kupersmith MJ, Miller NR, Levin LA (2017) New treatments in neuro-ophthalmology: the role for evidence. J Neuroophthalmol 37:1\u20132","journal-title":"J Neuroophthalmol"},{"key":"4711_CR9","doi-asserted-by":"publisher","first-page":"23","DOI":"10.2147\/EB.S125311","volume":"9","author":"S Berry","year":"2017","unstructured":"Berry S, Lin WV, Sadaka A, Lee AG (2017) Nonarteritic anterior ischemic optic neuropathy: cause, effect, and management. Eye Brain 9:23\u201328","journal-title":"Eye Brain"},{"key":"4711_CR10","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1097\/WNO.0b013e3181e1f71f","volume":"30","author":"AG Lee","year":"2010","unstructured":"Lee AG, Biousse V (2010) Should steroids be offered to patients with nonarteritic anterior ischemic optic neuropathy? J Neuroophthalmol 30:193\u2013198","journal-title":"J Neuroophthalmol"},{"key":"4711_CR11","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1007\/s00417-006-0441-0","volume":"245","author":"M Entezari","year":"2007","unstructured":"Entezari M, Rajavi Z, Sedighi N, Daftarian N, Sanagoo M (2007) High-dose intravenous methylprednisolone in recent traumatic optic neuropathy; a randomized double-masked placebo-controlled clinical trial. Graefes Arch Clin Exp Ophthalmol 245:1267\u20131271","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"4711_CR12","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1056\/NEJM199005173222001","volume":"322","author":"MB Bracken","year":"1990","unstructured":"Bracken MB, Shepard MJ, Collins WF, Holford TR, Young W, Baskin DS, Eisenberg HM, Flamm E, Leo-Summers L, Maroon J et al (1990) A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury. Results of the second national acute spinal cord injury study. N Engl J Med 322:1405\u20131411","journal-title":"N Engl J Med"},{"key":"4711_CR13","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1016\/S0161-6420(99)00707-1","volume":"106","author":"LA Levin","year":"1999","unstructured":"Levin LA, Beck RW, Joseph MP, Seiff S, Kraker R (1999) The treatment of traumatic optic neuropathy: the international optic nerve trauma study. Ophthalmology 106:1268\u20131277","journal-title":"Ophthalmology"},{"key":"4711_CR14","first-page":"389","volume":"21","author":"SR Seiff","year":"1990","unstructured":"Seiff SR (1990) High dose corticosteroids for treatment of vision loss due to indirect injury to the optic nerve. Ophthalmic Surg 21:389\u2013395","journal-title":"Ophthalmic Surg"},{"key":"4711_CR15","first-page":"14","volume":"2","author":"TC Spoor","year":"1996","unstructured":"Spoor TC, McHenry JG (1996) Management of traumatic optic neuropathy. J Craniomaxillofac Trauma 2:14\u201326 discussion 27","journal-title":"J Craniomaxillofac Trauma"},{"key":"4711_CR16","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.jns.2008.08.039","volume":"276","author":"V Biousse","year":"2009","unstructured":"Biousse V, Calvetti O, Drews-Botsch CD, Atkins EJ, Sathornsumetee B, Newman NJ (2009) Management of optic neuritis and impact of clinical trials: an international survey. J Neurol Sci 276:69\u201374","journal-title":"J Neurol Sci"},{"key":"4711_CR17","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1017\/S031716710000860X","volume":"35","author":"EJ Atkins","year":"2008","unstructured":"Atkins EJ, Drews-Botsch CD, Newman NJ, Calvetti O, Swanson S, Biousse V (2008) Management of optic neuritis in Canada: survey of ophthalmologists and neurologists. Can J Neurol Sci 35:179\u2013184","journal-title":"Can J Neurol Sci"},{"key":"4711_CR18","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1016\/j.jocn.2008.01.014","volume":"15","author":"CJ Lueck","year":"2008","unstructured":"Lueck CJ, Danesh-Meyer HV, Margrie FJ, Drews-Botsch C, Calvetti O, Newman NJ, Biousse V (2008) Management of acute optic neuritis: a survey of neurologists and ophthalmologists in Australia and New Zealand. J Clin Neurosci 15:1340\u20131345","journal-title":"J Clin Neurosci"},{"key":"4711_CR19","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1097\/00002341-200205000-00016","volume":"18","author":"KD Steinsapir","year":"2002","unstructured":"Steinsapir KD, Seiff SR, Goldberg RA (2002) Traumatic optic neuropathy: where do we stand? Ophthalmic Plast Reconstr Surg 18:232\u2013234","journal-title":"Ophthalmic Plast Reconstr Surg"},{"key":"4711_CR20","first-page":"157","volume":"17","author":"KD Steinsapir","year":"2000","unstructured":"Steinsapir KD, Goldberg RA, Sinha S, Hovda DA (2000) Methylprednisolone exacerbates axonal loss following optic nerve trauma in rats. Restor Neurol Neurosci 17:157\u2013163","journal-title":"Restor Neurol Neurosci"},{"key":"4711_CR21","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1097\/01.wno.0000204646.94991.68","volume":"26","author":"KD Steinsapir","year":"2006","unstructured":"Steinsapir KD (2006) Treatment of traumatic optic neuropathy with high-dose corticosteroid. J Neuroophthalmol 26:65\u201367","journal-title":"J Neuroophthalmol"},{"key":"4711_CR22","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1055\/s-0034-1393734","volume":"8","author":"AM Kumaran","year":"2015","unstructured":"Kumaran AM, Sundar G, Chye LT (2015) Traumatic optic neuropathy: a review. Craniomaxillofac Trauma Reconstr 8:31\u201341","journal-title":"Craniomaxillofac Trauma Reconstr"},{"key":"4711_CR23","doi-asserted-by":"publisher","first-page":"e46","DOI":"10.1016\/j.ophtha.2018.12.039","volume":"126","author":"SM Brown","year":"2019","unstructured":"Brown SM (2019) Re: Saxena et al.: steroids versus no steroids in nonarteritic anterior ischemic optic neuropathy: a randomized controlled trial (ophthalmology. 2018;125:1623-1627). Ophthalmology 126:e46\u2013e47","journal-title":"Ophthalmology"},{"key":"4711_CR24","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1136\/bjo.2010.191627","volume":"95","author":"M Modarres","year":"2011","unstructured":"Modarres M, Falavarjani KG, Nazari H, Sanjari MS, Aghamohammadi F, Homaii M, Samiy N (2011) Intravitreal erythropoietin injection for the treatment of non-arteritic anterior ischaemic optic neuropathy. Br J Ophthalmol 95:992\u2013995","journal-title":"Br J Ophthalmol"},{"key":"4711_CR25","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1007\/s00347-009-2030-1","volume":"107","author":"T Jehle","year":"2010","unstructured":"Jehle T, Meschede W, Dersch R, Feltgen N, Bach M, Lagreze WA (2010) Erythropoietin protects retinal ganglion cells and visual function after ocular ischemia and optic nerve compression. Ophthalmologe 107:347\u2013353","journal-title":"Ophthalmologe"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-020-04711-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00417-020-04711-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-020-04711-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,5]],"date-time":"2021-05-05T23:55:41Z","timestamp":1620258941000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00417-020-04711-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,6]]},"references-count":25,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["4711"],"URL":"https:\/\/doi.org\/10.1007\/s00417-020-04711-x","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"type":"print","value":"0721-832X"},{"type":"electronic","value":"1435-702X"}],"subject":[],"published":{"date-parts":[[2020,5,6]]},"assertion":[{"value":"3 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors. This study was approved by the Institutional Review Board of Myongji Hospital and followed the tenets of the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"This type of study does not require informed consent due to retrospective data collection.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}